Impact of Anticholinergics on the Aging Brain: A Review and Practical Application
Abstract
Objective: in an effort to enhance medication prescribing for older adults and reduce the burden of cognitive impairment, this paper reviews the literature regarding the negative impact of anticholinergics on cognitive function and provides clinicians with a practical guidance for anticholinergic use in older adults. Methods: a Medline search identified studies evaluating the use of anticholinergics and the relationship between anticholinergics and cognitive impairment. Results: prescribing anticholinergics for older adults leads to acute cognitive impairment and, possibly, chronic cognitive deficits. Assessing anticholinergic burden with a simple scale may represent a useful noninvasive tool to optimize geriatric pharmacotherapy. Conclusion: more studies are needed to validate the Anticholinergic Cognitive Burden scale and establish therapeutic guidelines in the presence of cognitive anticholinergic adverse effects.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Serum anticholinergic activity measured by a receptor bioassay does not correlate well with effects on cognition.
“Serum anticholinergic activity measured by a receptor bioassay does not correlate well with effects on cognition,16 28”
From Anticholinergic drugs and risk of dementia: case-control study (2018) · cites this paper as [16]
The study also included additional drugs from the Beers 2015 updated list of strong anticholinergic drugs, the Anticholinergic Cognitive Burden scale, a systematic review, and the British National Formulary.
“We also included additional drugs in the Beers 2015 updated list of strong anticholinergic drugs,15 drugs listed as having a high anticholinergic burden in the Anticholinergic Cognitive Burden scale,16 or identified as high-potency anticholinergics in a systematic review,17 and some further drugs identified as having substantial anticholinergic properties in the British National Formulary”
From Anticholinergic Drug Exposure and the Risk of Dementia: A Nested Case-Control Study (2019) · cites this paper as [16]
Cites
Implementing a screening and diagnosis program for dementia in primary care
Boustani, M., Callahan, C. M., Unverzagt, F. W., Austrom, M. G., Perkins, A. J., Fultz, B. A., Hui, S. L., & Hendrie, H. C. (2005) · Journal of General Internal Medicine · doi:10.1007/s11606-005-0103-7 · Cited by 374 · see citing works
Self-citation
Flagged first, then by citations
Research works printed but not linked: 44
- Vangala VR , TuethMJ: Chronic anticholinergic toxicity: identification and management in older patients.Geriatrics358, 36–37(2002).
- 10.1046/j.1532-5415.2002.50208.x · DOI
- 10.1097/00019442-199802000-00005 · DOI
- 10.1093/geronj/38.1.31 · DOI
- 10.1001/archpsyc.60.2.198 · DOI
- Tune LE : Anticholinergic effects of medication in elderly patients.J. Clin. Psychiatry62(Suppl. 21), 11–14(2001).
- 10.1001/archinte.1995.00430050035004 · DOI
- American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders (4th Edition). American Psychiatric Association Washington DC USA (1994).
- Boustani M ButtarA: Delirium. In: Primary Care Geriatrics a Case-Based Approach (5th Edition). Ham RJ Sloane PD Warshaw GA Bernard MA Flaherty E (Eds). Chapter 15 210–218(2007). · DOI
- Boustani M HamRJ: Alzheimer disease and other dementias. In: Primary Care Geriatrics a Case-Based Approach (5th Edition). Ham RJ Sloane PD Warshaw GA Bernard MA Flaherty E (Eds). Chapter 16 219–236(2007). · DOI
- 10.2147/cia.s1802 · DOI
- 10.7326/0003-4819-138-11-200306030-00015 · DOI
- 10.1016/S0140-6736(05)67889-0 · DOI
- 10.1046/j.1532-5415.5157.x · DOI
- 10.1124/jpet.102.041616 · DOI · Paper page
- 10.2174/092986706777935203 · DOI
- 10.1176/ajp.157.1.4 · DOI
- 10.1073/pnas.012467899 · DOI
- 10.1007/BF02244414 · DOI · Paper page
- 10.1007/BF02245172 · DOI · Paper page
- 10.1016/0197-4580(80)90022-6 · DOI
- 10.1097/00019442-200506000-00013 · DOI
- 10.1345/aph.18273 · DOI
- 10.1002/ana.10639 · DOI · Paper page
- 10.1592/phco.2005.25.11.1592 · DOI
- 10.1176/jnp.3.3.314 · DOI
- 10.1176/ajp.149.10.1393 · DOI
- 10.1111/j.1532-5415.2005.00543.x · DOI
- Ancellin ML , ArteroS, PortetF, DupuyAM, TouchonJ, RithieK: Non-degenerative mild cognitive impairment in elderly people and use of anticholinergic drugs: longitudinal cohort study.Br. Med. J.332(7539), 455–459(2006).
- 10.1177/0091270006292126 · DOI
- 10.1001/archpsyc.1980.01780160063007 · DOI
- 10.2165/00002512-199915010-00002 · DOI
- 10.1111/j.1532-5415.1995.tb06113.x · DOI
- 10.1001/archinte.161.8.1099 · DOI
- 10.1001/archinte.163.22.2716 · DOI · Paper page
- 10.2165/00002512-199303040-00004 · DOI
- 10.1097/00019442-200303000-00011 · DOI
- 10.1007/BF00433493 · DOI
- Boustani MA , LimbilT, CampbellN, Fox C, Maidment I: Anticholinergic burden: measurement and impact. J. Am. Geriatr. Soc.55, S52 (2007).
- 10.1097/01.JGP.0000224619.87681.71 · DOI
- 10.1345/aph.1G318 · DOI
- 10.1176/appi.ajp.162.3.627 · DOI
- 10.1001/archinternmed.2007.106 · DOI · Paper page
- Boustani M Peterson B Hanson L Harris R Krasnov C: Screening for dementia. Systematic evidence review. Agency for Healthcare Research and Quality Rockville MD USA (2003). www.ahrq.gov/clinic/uspstfix.htm · DOI
Cited by
Sorted by citations
The American Geriatrics Society 2012 Beers Criteria Update Expert Panel (2012) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2012.03923.x · Cited by 2,578 · see citing works
Cumulative Use of Strong Anticholinergics and Incident Dementia: A Prospective Cohort Study
Gray, S. L., Anderson, M. L., Dublin, S., Hanlon, J. T., Hubbard, R., Walker, R., Yu, O., Crane, P. K., & Larson, E. B. (2015) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2014.7663 · Cited by 1,111 · see citing works
Anticholinergic Drug Exposure and the Risk of Dementia: A Nested Case-Control Study
Coupland, C. A. C., Hill, T., Dening, T., Morriss, R., Moore, M., & Hippisley-Cox, J. (2019) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2019.0677 · Cited by 637 · see citing works
Anticholinergic drugs and risk of dementia: case-control study
Richardson, K., Fox, C., Maidment, I., Steel, N., Loke, Y. K., Arthur, A., Myint, P. K., Grossi, C. M., Mattishent, K., Bennett, K., et al. (2018) · BMJ · doi:10.1136/bmj.k1315 · Cited by 520 · see citing works
Self-citationAnticholinergics: theoretical and clinical overview
Nishtala, P. S., Salahudeen, M. S., & Hilmer, S. N. (2016) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2016.1165664 · Cited by 167 · see citing works
Implementing innovative models of dementia care: the healthy aging brain center
Boustani, M. A., Sachs, G. A., Alder, C. A., Munger, S., Schubert, C. C., Guerriero Austrom, M., Hake, A. M., Unverzagt, F. W., Farlow, M., Matthews, B. R., et al. (2011) · Aging & Mental Health · doi:10.1080/13607863.2010.496445 · Cited by 142 · see citing works
Anticholinergic Drug Burden in Older People's Brain - How well is it Measured?
Kersten, H., & Wyller, T. B. (2014) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.12140 · Cited by 112 · see citing works
Identifying potentially inappropriate prescribing in older people with dementia: a systematic review
Hukins, D., Macleod, U., & Boland, J. W. (2019) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-018-02612-x · Cited by 84 · see citing works
Kolanowski, A., Fick, D., Litaker, M., Mulhall, P., Clare, L., Hill, N., Mogle, J., Boustani, M., Gill, D., & Yevchak‐Sillner, A. (2016) · Journal of the American Geriatrics Society · doi:10.1111/jgs.14511 · Cited by 40 · see citing works
Self-citationKhan, W. U., Ghazala, Z., Brooks, H. J., Subramaniam, P., Mulsant, B. H., Kumar, S., Voineskos, A. N., Blumberger, D. M., Kern, R. S., & Rajji, T. K. (2021) · Schizophrenia Bulletin · doi:10.1093/schbul/sbaa093 · Cited by 27 · see citing works
Gastric acid suppressants and cognitive decline in people with or without cognitive impairment
Wu, C., Xiong, L. Y., Ouk, M., Rabin, J. S., Herrmann, N., Lanctôt, K. L., Kapral, M. K., Law, M., Cogo‐Moreira, H., Edwards, J. D., et al. (2022) · Alzheimer's & Dementia: Translational Research & Clinical Interventions · doi:10.1002/trc2.12243 · Cited by 13 · see citing works
- Authors
- Boustani, M., Campbell, N., Munger, S., Maidment, I., & Fox, C.
- Affiliations
- Regenstrief Institute (US)
- Sidney & Lois Eskenazi Hospital (US)
- St Martin's Hospital (GB)
- Shepway Caste Department of Old Age Psychiatry, Fokestone Health Centre,15–25 Dover Road, Folkestone, Kent, CT2 1JY, UK.
- Venue
- Aging Health
- Publisher
- Informa UK Limited
- Published
- 2008-06
- Volume
- 4
- Issue
- 3
- Pages
- 311-320
- ISSN
- 1745-509X (ISSN-L)
- 1745-5103
- OpenAlex
- W2095755860
- Cited by
- 862
- References
- 1
- Citations by year
- 2026: 93 · 2025: 90 · 2024: 92 · 2023: 70 · 2022: 61 · 2021: 69 · 2020: 94 · 2019: 61 · 2018: 41 · 2017: 42 · 2016: 36 · 2015: 36 · 2014: 28 · 2013: 20 · 2012: 13
- FWCI
- 4.19
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Aging Health (publishedVersion)
- UEA Digital Repository (University of East Anglia) (submittedVersion)
- Topics
- Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Intensive Care Unit Cognitive Disorders
- Keywords
- anticholinergic agents, cognitive impairment, older adults, anticholinergic burden, Anticholinergic Cognitive Burden Scale, geriatric pharmacotherapy, drug prescribing, cognitive decline, adverse drug reactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review